P-Cadherin (CDH3) Peptide
CDH3
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN937001
Quick Overview for P-Cadherin (CDH3) Peptide (ABIN937001)
Target
P-Cadherin (CDH3)
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- AVSENGASVE DPMNISIIVT DQNDHKPKFT QDTFRGSVLE GVLPGTSVMQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CDH3 antibody,
Alternative Names: CDH3 control peptide, CDH3 antibody Blocking Peptide, Anti-CDH3 Blocking Peptide, Cadherin 3 Type 1 Blocking Peptide, P-Cadherin Blocking Peptide, CDHP Blocking Peptide, HJMD Blocking Peptide, PCAD Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- P-Cadherin (CDH3)
-
Background
- CDH3 is a classical cadherin from the cadherin superfamily. The protein is a calcium-dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Its gene is located in a six-cadherin cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. In addition, aberrant expression of this protein is observed in cervical adenocarcinomas. Mutations in its gene have been associated with congential hypotrichosis with juvenile macular dystrophy.
-
Molecular Weight
- 91 kDa
Target
-
You are here:
